Stocks · Healthcare · Medical - Devices
Lucid Diagnostics Inc. LUCD
$0.63 -1.18% Close, Oct 2, 2026 · NASDAQ · Market cap $119.7M
Strong growthWeak trendExpensive vs sector
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -930.9% from -1099.5% a year earlier.
- The diluted share count rose 85.0% in a year.
- The stock is 57% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 28%
- Revenue growth, 3-year CAGRTop 5%
- Revenue growth accelerationTop 29%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 5%
- Gross marginBottom 7%
- Operating marginBottom 12%
- Accruals (lower is better)Top 25%
- Interest coverBottom 4%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 9%
- Free-cash-flow yieldBottom 12%
- EBITDA / enterprise valueBottom 14%
- Sales / enterprise valueBottom 20%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 34%
- 6-month returnBottom 6%
- 1-year return vs S&P 500Bottom 16%
- Distance from 52-week highBottom 15%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 16%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetTop 18%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 22%
- Maximum drawdown, 3 yearsTop 38%
- Beta vs S&P 500 (lower is better)Top 13%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 23.0% | 24.9% | ↑ |
| Gross margin | -64.3% | -25.8% | ↑ |
| Operating margin | -1099.5% | -930.9% | ↑ |
| FCF margin | -1004.3% | -866.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 24.9% | 23.0% | ↑ | Top 28% |
| Gross margin | -25.8% | -64.3% | ↑ | Bottom 7% |
| Operating margin | -930.9% | -1099.5% | ↑ | Bottom 12% |
| Net margin | -959.8% | -1267.4% | ↑ | — |
| Free-cash-flow margin | -866.6% | -1004.3% | ↑ | — |
| Return on invested capital | -141.4% | — | Bottom 5% | |
| Revenue growth, 3-year CAGR | 132.0% | — | Top 5% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -13.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 42205.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +166.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -2815.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -41.35%
- Shareholder yield
- -41.35%
- Share count change, 1 year
- +85.0%
- Share count change, 3-year CAGR
- +63.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 12, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 0 of 8
- Average EPS surprise, last 4
- -38.8%
- Average 2-day reaction, last 8
- +1.7%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $2.00
- Target vs current price
- +218.8%
- Analysts with a rating
- 6
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | -5.9% | -2.0% | +2.6% | -18.3% | — |
| May 14, 2026 | -40.0% | +0.0% | -2.0% | -4.1% | -5.8% |
| Mar 25, 2026 | -42.9% | -0.8% | -4.2% | +9.2% | -10.0% |
| Nov 12, 2025 | -66.7% | +6.7% | +1.0% | +9.6% | +18.3% |
| Aug 13, 2025 | -11.1% | -1.6% | -0.4% | +2.3% | +9.3% |
| May 14, 2025 | -77.8% | +7.6% | +9.2% | +7.6% | -16.3% |
| Mar 24, 2025 | -26.7% | -1.3% | +3.9% | -21.1% | -19.1% |
| Nov 13, 2024 | -25.0% | +5.0% | -4.4% | -23.8% | +28.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.06 | -$0.06 | -5.9% | $1.5M |
| May 14, 2026 | -$0.07 | -$0.05 | -40.0% | $1.3M |
| Mar 25, 2026 | -$0.10 | -$0.07 | -42.9% | $1.5M |
| Nov 12, 2025 | -$0.10 | -$0.06 | -66.7% | $1.2M |
| Aug 13, 2025 | -$0.10 | -$0.09 | -11.1% | $1.2M |
| May 14, 2025 | -$0.16 | -$0.09 | -77.8% | $828,000 |
| Mar 24, 2025 | -$0.19 | -$0.15 | -26.7% | $1.2M |
| Nov 13, 2024 | -$0.20 | -$0.16 | -25.0% | $1.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 20.42× | — | — | Bottom 20% |
| Free-cash-flow yield | -39.43% | — | — | Bottom 12% |
| Earnings yield | -74.30% | — | — | Bottom 9% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.7%
- 200-day average slope (20 days)
- -2.4%
- Distance from 50-day average
- -30.2%
- Distance from 200-day average
- -42.4%
- RSI (14)
- 25.7
- Relative volume
- 1.48×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 75.1%
- Volatility vs own 5-year history
- 77th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.44
- Correlation with S&P 500
- 0.10
- Current drawdown from 1-year high
- -57.3%
- Maximum drawdown, 3 years
- -62.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Oct 14, 2021 | Oct 2, 2026 | -94.7% | 1246 days | Not yet recovered |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $119.7M
- EPS, diluted (TTM)
- -$0.47
- Revenue (TTM)
- $5.4M
- 52-week range
- $0.50 – $1.63
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $500,000 | $377,000 | $2.4M | $4.3M | $4.7M |
| Gross profit | -$85,000 | -$3.2M | -$6.0M | -$3.9M | -$2.8M |
| Operating income | -$27.4M | -$56.2M | -$48.5M | -$46.1M | -$49.6M |
| Net income | -$28.1M | -$56.2M | -$52.7M | -$45.5M | -$58.0M |
| EPS (diluted) | -$0.78 | -$1.55 | -$1.26 | -$1.05 | -$0.69 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2M | $1.2M | $828,000 | $1.2M | $1.2M | $1.5M | $1.3M | $1.5M |
| Net income | -$12.4M | -$11.5M | -$26.9M | -$4.4M | -$10.4M | -$16.3M | -$13.9M | -$11.7M |
| EPS (diluted) | -$0.25 | -$0.20 | -$0.52 | -$0.08 | -$0.10 | -$0.12 | -$0.17 | -$0.08 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$17.7M | -$29.7M | -$32.8M | -$44.1M | -$46.5M |
| Capital expenditure | -$862,000 | -$908,000 | -$221,000 | -$646,000 | -$197,000 |
| Free cash flow | -$18.5M | -$30.6M | -$33.0M | -$44.8M | -$46.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $70.0M | $1.8M | $284,000 | $451,000 | $58.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $33.4M
- Total assets
- $38.9M
- Total liabilities
- $28.0M
- Total debt
- $24.9M
- Net debt
- -$8.5M
- Shareholders’ equity
- $10.9M
As of Jun 30, 2026 (filed Aug 12, 2026).
Short interest
- Shares sold short
- 12,830,303
- Days to cover
- 12.48
- Change vs previous report
- +7.9%
FINRA short interest, settlement date Sep 15, 2026.